ASCO 2014: Dr. Furman Gives us Perspective on Resistance with Ibrutinib in CLL


The whole issue of late onset resistance to ibrutinib and other TKIs is a growing area of concern and research.

I will posting more on it in my blog ( ), but Dr. Furman gives us a nice starting perspective.

Stay strong


Admin: Links now working (HU will not cope with any characters adjacent to the end of the link and it is best to have spaces before and after links.)

Last edited by

1 Reply

  • Excellent video. Thank you. Made me feel very positive. I am about to start on Ibrutinib.

You may also like...